<b><i>ITPA</i></b> and <b><i>SLC29A1</i></b> Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors

Andrea Lombardi, Felicia Stefania Falvella, C. Magni et al.|Pharmacology|2015

Cited by 2